Advertisement

Author: Janine Anthes

April 2020 Briefing – Nursing

Here are what the editors at HealthDay consider to be the most important developments in Nursing for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – OBGYN & Women’s Health

Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in […]

Read More

April 2020 Briefing – Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. […]

Read More

April 2020 Briefing – Ophthalmology

Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Orthopedics

Here are what the editors at HealthDay consider to be the most important developments in Orthopedics for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Pediatrics

Here are what the editors at HealthDay consider to be the most important developments in Pediatrics for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Psychiatry

Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Pulmonology

Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Rheumatology

Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Surgery

Here are what the editors at HealthDay consider to be the most important developments in Surgery for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Urology

Here are what the editors at HealthDay consider to be the most important developments in Urology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Internal Medicine

Here are what the editors at HealthDay consider to be the most important developments in Internal Medicine for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened […]

Read More

April 2020 Briefing – Critical Care

Here are what the editors at HealthDay consider to be the most important developments in Critical Care for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened […]

Read More

April 2020 Briefing – Emergency Medicine

Here are what the editors at HealthDay consider to be the most important developments in Emergency Medicine for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened […]

Read More

April 2020 Briefing – Otolaryngology

Here are what the editors at HealthDay consider to be the most important developments in Otolaryngology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Nephrology

Here are what the editors at HealthDay consider to be the most important developments in Nephrology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Pathology

Here are what the editors at HealthDay consider to be the most important developments in Pathology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Radiology

Here are what the editors at HealthDay consider to be the most important developments in Radiology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Anesthesiology

Here are what the editors at HealthDay consider to be the most important developments in Anesthesiology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Cosmetic Surgery

Here are what the editors at HealthDay consider to be the most important developments in Cosmetic Surgery for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened […]

Read More

For latest news and updates
Email-id is invalid